Global Drug Abuse Testing Products Market Growth (Status and Outlook) 2024-2030

Global Drug Abuse Testing Products Market Growth (Status and Outlook) 2024-2030

Drug abuse test is a non-invasive technical analysis of biological samples such as blood, hair, urine, and others, to diagnose the presence of illegal, prescription drugs, or their metabolites. Among these urine testing is the most preferred sample type used for drugs of abuse testing. Drug testing offers a critical adjunct to clinical care and substance use. Drug testing is now increasingly being used by sports organizations, employers, forensic purposes, and several other applications.



The global Drug Abuse Testing Products market size is projected to grow from US$ 9491 million in 2024 to US$ 15540 million in 2030; it is expected to grow at a CAGR of 8.6% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Drug Abuse Testing Products Industry Forecast” looks at past sales and reviews total world Drug Abuse Testing Products sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Abuse Testing Products sales for 2023 through 2029. With Drug Abuse Testing Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Abuse Testing Products industry.

This Insight Report provides a comprehensive analysis of the global Drug Abuse Testing Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug Abuse Testing Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Abuse Testing Products market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Abuse Testing Products and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Abuse Testing Products.

The surge in number of people who consume alcohol and illicit drugs such as marijuana, cocaine, and others, is one of the major drivers for the drug abuse testing market. In addition, technological advancements in drug screening/testing devices and stringent government regulations mandating drug screening boost the market growth. However, lack of awareness and consideration of drug testing as a breach of privacy rights in certain countries restrict the growth of the global drug abuse testing market. Emerging markets such as the Asia-Pacific and LAMEA, provide lucrative opportunities for the drug abuse testing market growth.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug Abuse Testing Products market by product type, application, key players and key regions and countries.

Segmentation by Type:
Analyzers
Rapid Testing Devices
Consumables

Segmentation by Application:
Workplaces and Schools
Criminal Justice Systems and Law Enforcement Agencies
Hospitals
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Analyzers
Rapid Testing Devices
Consumables

Segmentation by Application:
Workplaces and Schools
Criminal Justice Systems and Law Enforcement Agencies
Hospitals
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biomedical Diagnostics
BioMerieux
Abbott Laboratories
Bio-Rad
Dako
DiaSorin
Eiken
Fujirebio
Beckman Coulter
Siemens
F. Hoffmann-La Roche Ltd. (Genentech Inc.)
Laboratory Corporation Of America Holdings
Danaher Corporation
Express Diagnostics International Inc
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc
Drgerwerk Ag & Co.
Kgaa

Please note: The report will take approximately 2 business days to prepare and deliver.